News
![Form 8.3 - The Vanguard Group, Inc.: National Express Group plc](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
![Form 8.3 - The Vanguard Group, Inc.: Meggitt plc](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
![Form 8.3 - The Vanguard Group, Inc.: Avast plc](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
![DGAP-News: UMT Group publishes Letter to the Shareholders: Strong growth also expected for full year 2021, guidance confirmed](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
DGAP-News: UMT Group publishes Letter to the Shareholders: Strong growth also expected for full year 2021, guidance confirmed
DGAP-News: UMT Group publishes Letter to the Shareholders: Strong growth also expected for full year 2021, guidance confirmed
![Hardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Hardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!
Hardman & Co Video : Hardman Talks | Everything you wanted to know about private equity but were afraid to ask!
![MMC Norilsk Nickel: Notification and public disclosure of transactions by persons discharging managerial responsibilities / persons closely associated with them](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
MMC Norilsk Nickel: Notification and public disclosure of transactions by persons discharging managerial responsibilities / persons closely associated with them
MMC Norilsk Nickel: Notification and public disclosure of transactions by persons discharging managerial responsibilities / persons closely associated with them
![Director/PDMR Shareholding](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Director/PDMR Shareholding
Director/PDMR Shareholding
![Chelverton UK Dividend Trust plc: Net Asset Value(s)](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
![DGAP-Adhoc: windeln.de SE: Convening of an extraordinary general meeting to report a loss pursuant to Sec. 92 German Stock Corporation Act and to resolve on an ordinary capital reduction and a capital increase](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
DGAP-Adhoc: windeln.de SE: Convening of an extraordinary general meeting to report a loss pursuant to Sec. 92 German Stock Corporation Act and to resolve on an ordinary capital reduction and a capital increase
DGAP-Adhoc: windeln.de SE: Convening of an extraordinary general meeting to report a loss pursuant to Sec. 92 German Stock Corporation Act and to resolve on an ordinary capital reduction and a capital increase
![DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021
DGAP-News: Dermapharm Holding SE raises EBITDA forecast for the full year 2021
![DGAP-News: Sernova Announces Clinical Investigator Update of its Type 1 Diabetes Trial at the 2022 ASTS 22nd Annual Winter Symposium](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DGAP-News: Sernova Announces Clinical Investigator Update of its Type 1 Diabetes Trial at the 2022 ASTS 22nd Annual Winter Symposium
DGAP-News: Sernova Announces Clinical Investigator Update of its Type 1 Diabetes Trial at the 2022 ASTS 22nd Annual Winter Symposium
![DGAP-News: Medios AG adopts sustainability strategy and plans climate neutrality by 2023](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
DGAP-News: Medios AG adopts sustainability strategy and plans climate neutrality by 2023
DGAP-News: Medios AG adopts sustainability strategy and plans climate neutrality by 2023
![Magnit to build greenhouses for growing strawberries and blueberries](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Magnit to build greenhouses for growing strawberries and blueberries
Magnit to build greenhouses for growing strawberries and blueberries
![DGAP-News: Allterco еnters heating control market](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
DGAP-News: Allterco еnters heating control market
DGAP-News: Allterco еnters heating control market
![Holding(s)in company](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Holding(s)in company
Holding(s)in company
![DGAP-News: Wacker Chemie AG: WACKER Sets New Corporate Sustainability Goals](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-News: Wacker Chemie AG: WACKER Sets New Corporate Sustainability Goals
DGAP-News: Wacker Chemie AG: WACKER Sets New Corporate Sustainability Goals
![DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad participates in NewtonX's $32m Series B funding round](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad participates in NewtonX's $32m Series B funding round
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad participates in NewtonX's $32m Series B funding round
![Lyxor International Asset Management: DELISTINGS - 9 shares classes - London Stock Exchange](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
Lyxor International Asset Management: DELISTINGS - 9 shares classes - London Stock Exchange
Lyxor International Asset Management: DELISTINGS - 9 shares classes - London Stock Exchange
![DGAP-News: Knaus Tabbert AG: Knaus Tabbert AG strengthens financial flexibility](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DGAP-News: Knaus Tabbert AG: Knaus Tabbert AG strengthens financial flexibility
DGAP-News: Knaus Tabbert AG: Knaus Tabbert AG strengthens financial flexibility
![Petrofac Limited: Trading Update](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Petrofac Limited: Trading Update
Petrofac Limited: Trading Update
![Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3
![Samarkand Group plc : Interim Results](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Samarkand Group plc : Interim Results
Samarkand Group plc : Interim Results
![Travis Perkins: Transaction in Own Shares](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
![DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen
DGAP-News: VIB Vermögen AG: Joint Venture VIB/WDP rents out 46.000 sqm in Gelsenkirchen
![DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO